HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation
about
Implication of indolamine 2,3 dioxygenase in the tolerance toward fetuses, tumors, and allograftsInterferon-alpha, immune activation and immune dysfunction in treated HIV infectionThe simian immunodeficiency virus targets central cell cycle functions through transcriptional repression in vivoLeukocyte-derived IFN-α/β and epithelial IFN-λ constitute a compartmentalized mucosal defense system that restricts enteric virus infectionsNew Insights into IDO Biology in Bacterial and Viral Infections.Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cellsType I interferon: friend or foe?Major depletion of plasmacytoid dendritic cells in HIV-2 infection, an attenuated form of HIV diseaseCycling memory CD4+ T cells in HIV disease have a diverse T cell receptor repertoire and a phenotype consistent with bystander activation.Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation.Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1.Plasmacytoid dendritic cells in HIV infection: striking a delicate balance.Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?In acute pathogenic SIV infection plasmacytoid dendritic cells are depleted from blood and lymph nodes despite mobilization.Dynamics of regulatory T-cells during pregnancy: effect of HIV infection and correlations with other immune parameters.Highly active antiretroviral therapy potently suppresses HIV infection in humanized Rag2-/-gammac-/- miceSoluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm.The immunosuppressive role of IL-32 in lymphatic tissue during HIV-1 infectionHIV-1 Tat protein induces the production of IDO in human monocyte derived-dendritic cells through a direct mechanism: effect on T cells proliferation.Dissecting the role of dendritic cells in simian immunodeficiency virus infection and AIDSPlasma kynurenic acid concentration in patients undergoing cardiac surgery: effect of anaesthesia.Structural variants of IFNα preferentially promote antiviral functions.Plasmacytoid dendritic cells are recruited to the colorectum and contribute to immune activation during pathogenic SIV infection in rhesus macaques.Gut inflammation and indoleamine deoxygenase inhibit IL-17 production and promote cytotoxic potential in NKp44+ mucosal NK cells during SIV infection.Indoleamine 2,3-dioxygenase in human hematopoietic stem cell transplantation.Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infectionOveractivation of plasmacytoid dendritic cells inhibits antiviral T-cell responses: a model for HIV immunopathogenesis.Blocking type I interferon production: a new therapeutic option to reduce the HIV-1-induced immune activationSelective Blockade of Interferon-α and -β Reveals Their Non-Redundant Functions in a Mouse Model of West Nile Virus InfectionIndoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis.HIV-1 Env and Nef Cooperatively Contribute to Plasmacytoid Dendritic Cell Activation via CD4-Dependent MechanismsType 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection.Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting rhesus macaques from vaginal simian immunodeficiency virus challenge.Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance.Cocaine Use May be Associated with Increased Depression in Persons Infected with HIV.HIV-1 and HIV-2 differentially mature plasmacytoid dendritic cells into IFN-producing cells or APCs.TREX1 Knockdown Induces an Interferon Response to HIV that Delays Viral Infection in Humanized Mice.Immunology. An interferon paradoxThe role of cytokines in the pathogenesis and treatment of HIV infection
P2860
Q26825202-D1F273C8-A21A-4680-BC98-E3EE881EEFFDQ26861003-59AD6E99-4607-421E-BD84-9E24513AA781Q27317391-AF30954E-F22C-438C-A191-26C355CE47C5Q27320523-FEEA595E-8F68-4804-A90F-1C78F87B13B6Q27692028-BBECC8E2-E94D-4F20-9508-EB5733031EA0Q28068375-5466FAD6-CFDB-431A-8F1B-591B927E4B5DQ28293186-1444C306-706D-4265-A407-616189AE32E3Q30912292-C97BE0D0-0CE0-4D1E-8822-77B230F35B4AQ33602906-F9DC8486-D411-4426-9970-993C9CD965FAQ33613674-A8554CAA-5403-48F1-B2AE-1389540A2F69Q33649753-61649B53-4657-42A7-B208-6A349A4F00EDQ33805319-C03AE9EB-AA48-4752-826C-4824252BA211Q33992829-B0CB51D2-04A4-40EE-A08F-83D93838A023Q33997605-DCC44104-84D1-46C9-AF43-B5B994E6ADDBQ34091313-5F1BBA96-14A0-4B85-A344-EB26C4DD736EQ34100221-9DCB4BFD-977A-4570-B9B9-60B431BFADEDQ34315579-667025CC-3212-42D4-A86A-81F5AE7EAF55Q34608946-5667AC7C-080B-4BE7-BE48-D6D321FAD2A2Q34995534-EFC1960C-6283-477D-ACF3-AC8899D8A51CQ35000687-D670711C-2AFD-4B73-8DE2-33D48CD98662Q35118991-C076164E-BEE8-49A8-A621-BF7A683B7C66Q35176244-2B78CC60-DEE8-4DE2-8100-AA03D93C980AQ35197399-81CD5B8B-D24D-4F83-B324-C0F25C019A67Q35212361-EEE3D421-16A2-40C8-A275-347896D80FE9Q35230224-19CFB97D-7360-4504-B402-FCBD60EE78E3Q35366857-4B9AF943-4288-4D39-B085-14D1602176D6Q35531527-C48A9041-945E-4B97-8776-AA220A273D17Q35553567-6CEF8FF1-D1EC-4F06-9B35-CB8BCBA891FFQ35606616-7CC97E85-03F5-41BF-95A2-A8E444F0B244Q35641152-5DDC6BFE-77FD-423E-B340-D5E251F3D7FAQ35674541-9DF026CE-58F7-4817-A387-36BB0C9695E5Q35861175-616712F5-254F-4CE0-98C9-32B59DFD9EB3Q36071793-86F360AE-A045-4F39-A6CC-2CF40F28B350Q36154801-557B2CA3-9B3D-4D14-97FF-3562F232DA89Q36426325-7FB159C3-303F-4209-B781-C9395E1399FBQ36586210-4C9415E8-4EFA-4ADD-9E95-3F60FFC6BE49Q36770954-F86056CE-1623-45F3-A30A-00B0FD3EB352Q36938999-76E17922-F4BD-475A-83FB-0ACADE5D4C53Q36949540-1D268C1F-3CB2-4236-801A-63D85BBFA034Q37053199-88D83216-7FA3-4198-894D-FEE31DDFC0FD
P2860
HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
HIV-induced type I interferon ...... despite phenotypic activation
@ast
HIV-induced type I interferon ...... despite phenotypic activation
@en
type
label
HIV-induced type I interferon ...... despite phenotypic activation
@ast
HIV-induced type I interferon ...... despite phenotypic activation
@en
prefLabel
HIV-induced type I interferon ...... despite phenotypic activation
@ast
HIV-induced type I interferon ...... despite phenotypic activation
@en
P2093
P2860
P1433
P1476
HIV-induced type I interferon ...... despite phenotypic activation
@en
P2093
Andrew W Hardy
Gene M Shearer
Matthew J Dolan
Stephanie A Anderson
P2860
P356
10.1371/JOURNAL.PONE.0002961
P407
P577
2008-08-13T00:00:00Z